The basis for immunotherapy in multiple myeloma
Ignacio Melero Bermejo
Myeloma 2016: Panel discussion on the new treatment paradigm
Gareth Morgan et al.
Panel discussion on immune therapies for lymphoma - CAR T-cell therapy and the question of cure
Anas Younes et al.
Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.